NRC Health (NRC): Operating Income

Annual figures by period end, from SEC filings.

$22.59M
Year ended 2025-12-31
$14.74M
Trailing 12 months to 2026-06-30
-21.4%
3-year compound annual growth
-11.9%
5-year compound annual growth
-1.6%
10-year compound annual growth
$50.27M2009-12-31: $13.70M2010-12-31: $13.86M2011-12-31: $18.73M2012-12-31: $22.72M2013-12-31: $24.81M2014-12-31: $28.30M2015-12-31: $26.45M2016-12-31: $31.20M2017-12-31: $34.22M2018-12-31: $35.27M2019-12-31: $43.03M2020-12-31: $42.68M2021-12-31: $50.27M2022-12-31: $46.54M2023-12-31: $40.05M2024-12-31: $35.19M2025-12-31: $22.59M$22.59M
2009-12-31 Operating Income (USD) 2025-12-31
Period endedOperating IncomeChange YoYSource filing
2025-12-31$22.59M-35.8%2026-03-05, From 2025-01-01
2024-12-31$35.19M-12.1%2026-03-05, From 2024-01-01
2023-12-31$40.05M-14.0%2026-03-05, From 2023-01-01
2022-12-31$46.54M-7.4%2025-03-17, From 2022-01-01
2021-12-31$50.27M+17.8%2024-02-27, From 2021-01-01
2020-12-31$42.68M-0.8%2023-03-03, From 2020-01-01
2019-12-31$43.03M+22.0%2022-03-04, From 2019-01-01
2018-12-31$35.27M+3.1%2021-03-05, From 2018-01-01
2017-12-31$34.22M+9.7%2020-03-06, From 2017-01-01
2016-12-31$31.20M+18.0%2019-03-08, From 2016-01-01
2015-12-31$26.45M-6.5%2018-03-14, From 2015-01-01
2014-12-31$28.30M+14.1%2017-03-03, From 2014-01-01
2013-12-31$24.81M+9.2%2016-03-04, From 2013-01-01
2012-12-31$22.72M+21.3%2015-03-04, From 2012-01-01
2011-12-31$18.73M+35.2%2014-03-04, From 2011-01-01
2010-12-31$13.86M+1.2%2013-03-01, From 2010-01-01
2009-12-31$13.70Mn/a2012-03-01, From 2009-01-01

Operating Income at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating IncomeChange YoY
NRC Health (NRC)2025-12-31$22.59M-35.8%
MaxCyte, Inc. (MXCT)2025-12-31-$51.90Mn/m
OmniAb, Inc. (OABI)2025-12-31-$68.97Mn/m
Foxo Technologies Inc. (FOXO)2025-12-31-$10.33Mn/m
Medpace Holdings, Inc. (MEDP)2025-12-31$534.93M+19.7%
bioAffinity Technologies, Inc. (BIAF)2025-12-31-$10.57Mn/m
Charles River Laboratories International, Inc. (CRL)2025-12-27$25.16M-88.9%
Incyte Corp (INCY)2025-12-31$1.51Bn/m
Absci Corp (ABSI)2025-12-31-$120.32Mn/m

Compare NRC, MXCT, OABI, FOXO side by side · Screen every company in Services-Commercial Physical & Biological Research ↗